CELZ Creative Medical Technology Holdings, Inc.
HealthcareAs of 2026-05-25
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
1.45
P/S
2055.92
EV/EBITDA
-0.08
DCF Value
$2.95
FCF Yield
-90.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
-3986.6%
Operating Margin
-198049.6%
Net Margin
-192066.3%
ROE
-88.5%
ROA
-89.5%
ROIC
-96.9%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $0.00 | $-1.4M | $— |
| Q4 null | $3.0K | $-1.9M | $— |
| FY null | $6.0K | $-6.0M | $— |
| Q3 null | $0.00 | $-1.2M | $— |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
—
Beta
1.85
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.